Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation - PubMed (original) (raw)
Case Reports
. 2006 Nov;118(5):e1584-92.
doi: 10.1542/peds.2005-2882. Epub 2006 Oct 9.
Affiliations
- PMID: 17030597
- DOI: 10.1542/peds.2005-2882
Case Reports
Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation
Andrea Bernasconi et al. Pediatrics. 2006 Nov.
Abstract
STAT5 proteins are components of the common growth hormone and interleukin 2 family of cytokines' signaling pathway. Mutations in the STAT5b gene, described in 2 patients, lead to growth hormone insensitivity that resembles Laron syndrome. Clinical immunodeficiency was also present, although immunologic defects have not been well characterized thus far. Here we describe a 16-year-old girl who suffered generalized eczema and recurrent infections of the skin and respiratory tract since birth. She also suffered severe chronic lung disease and multiple episodes of herpetic keratitis. Clinical features of congenital growth hormone deficiency were observed, such as persistently low growth rate, severely delayed bone age, and postnatal growth failure resulting from growth hormone resistance. This combined phenotype of growth hormone insensitivity and immunodeficiency was attributable to a homozygous C-->T transition that resulted in a nonsense mutation at codon 152 in exon 5 of the STAT5b gene. This novel mutation determined a complete absence of protein expression. The main immunologic findings were moderate T-cell lymphopenia (1274/mm3), normal CD4/CD8 ratio, and very low numbers of natural killer (18/mm3) and gammadelta T (5/mm3) cells. T cells presented a chronically hyperactivated phenotype. In vitro T-cell proliferation and interleukin 2 signaling were impaired. CD4+ and CD25+ regulatory T cells were significantly diminished, and they probably contributed to the signs of homeostatic mechanism deregulation found in this patient. This new case, in accordance with 2 previously reported cases, definitely demonstrates the significant role of the STAT5b protein in mediating growth hormone actions. Furthermore, the main immunologic findings bring about an explanation for the clinical immunodeficiency features and reveal for the first time the relevant role of STAT5b as a key protein for T-cell functions in humans.
Similar articles
- Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene.
Hwa V, Camacho-Hübner C, Little BM, David A, Metherell LA, El-Khatib N, Savage MO, Rosenfeld RG. Hwa V, et al. Horm Res. 2007;68(5):218-24. doi: 10.1159/000101334. Epub 2007 Mar 28. Horm Res. 2007. PMID: 17389811 - [New molecular mechanisms of growth hormone insensitivity].
Edouard T, Raynal P, Yart A, Conte-Auriol F, Salles JP, Tauber M. Edouard T, et al. Arch Pediatr. 2008 Feb;15(2):179-88. doi: 10.1016/j.arcped.2007.10.023. Epub 2008 Jan 18. Arch Pediatr. 2008. PMID: 18207712 Review. French. - STAT5b deficiency: lessons from STAT5b gene mutations.
Hwa V, Nadeau K, Wit JM, Rosenfeld RG. Hwa V, et al. Best Pract Res Clin Endocrinol Metab. 2011 Feb;25(1):61-75. doi: 10.1016/j.beem.2010.09.003. Best Pract Res Clin Endocrinol Metab. 2011. PMID: 21396575 Review. - Growth hormone insensitivity resulting from post-GH receptor defects.
Rosenfeld RG, Kofoed E, Little B, Woods K, Buckway C, Pratt K, Hwa V. Rosenfeld RG, et al. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S35-8. doi: 10.1016/j.ghir.2004.03.009. Growth Horm IGF Res. 2004. PMID: 15135774 - Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ, Wei H, Cao LZ, Lu JJ, Luo XP. Ying YQ, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2007 Aug;9(4):335-8. Zhongguo Dang Dai Er Ke Za Zhi. 2007. PMID: 17706034
Cited by
- Long-term follow-up of STAT5B deficiency in three argentinian patients: clinical and immunological features.
Bezrodnik L, Di Giovanni D, Caldirola MS, Azcoiti ME, Torgerson T, Gaillard MI. Bezrodnik L, et al. J Clin Immunol. 2015 Apr;35(3):264-72. doi: 10.1007/s10875-015-0145-5. Epub 2015 Mar 11. J Clin Immunol. 2015. PMID: 25753012 - Empowering Regulatory T Cells in Autoimmunity.
Kasper IR, Apostolidis SA, Sharabi A, Tsokos GC. Kasper IR, et al. Trends Mol Med. 2016 Sep;22(9):784-797. doi: 10.1016/j.molmed.2016.07.003. Epub 2016 Jul 25. Trends Mol Med. 2016. PMID: 27461103 Free PMC article. Review. - Developmental Adaptive Immune Defects Associated with STAT5B Deficiency in Three Young Siblings.
Foley CL, Al Remeithi SS, Towe CT, Dauber A, Backeljauw PF, Tyzinski L, Kumar AR, Hwa V. Foley CL, et al. J Clin Immunol. 2021 Jan;41(1):136-146. doi: 10.1007/s10875-020-00884-6. Epub 2020 Oct 22. J Clin Immunol. 2021. PMID: 33090292 Free PMC article. - Mouse models of growth hormone insensitivity.
Young J, Bell S, Qian Y, Hyman C, Berryman DE. Young J, et al. Rev Endocr Metab Disord. 2021 Mar;22(1):17-29. doi: 10.1007/s11154-020-09600-6. Epub 2020 Oct 10. Rev Endocr Metab Disord. 2021. PMID: 33037595 Free PMC article. Review. - Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, Noel RJ, Verbsky JW, Freeman AF, Janssen E, Bonilla FA, Pechacek J, Chandrasekaran P, Browne SK, Agharahimi A, Gharib AM, Mannurita SC, Yim JJ, Gambineri E, Torgerson T, Tran DQ, Milner JD, Holland SM. Uzel G, et al. J Allergy Clin Immunol. 2013 Jun;131(6):1611-23. doi: 10.1016/j.jaci.2012.11.054. Epub 2013 Mar 25. J Allergy Clin Immunol. 2013. PMID: 23534974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous